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Abstract
Background: The SCORE system is a simple, currently recommended method of cardiovas-
cular risk assessment. The aim of this study is to determine the relationship between SCORE
risk and intima media thickness (IMT) and flow mediated dilatation (FMD) in a low risk
population.
Methods: 119 people (59 men) without known cardiovascular disease and estimated by
means of SCORE system risk < 5%, were included in the study. The ultrasound method was
used to assess brachial artery diameter (BAd), FMD, nitroglycerin mediated dilatation (NMD)
of brachial artery and IMT of common carotid. FMD × BAd and FMD/NMD indexes represent-
ing hyperemia-induced vasodilatation independent of brachial artery properties were analyzed.
Results: IMT measured was 0.52 ± 0.08 mm; FMD: 17.5 ± 7.8%; NMD: 27.0 ± 9.0%;
FMD × BAd: 58.2 ± 22.4, FMD/NMD: 0.64 ± 0.19. Independent predictor for both FMD and
NMD was BAd (R2 –0.31; p < 0.001; R2 –0.44; p < 0.001; respectively), for FMD × BAd
index and FMD/NMD index was IMT (R2 –0.04; p = 0.02; R2 –0.04; p = 0.015) in a multivariate
analysis. Risk estimated by use of the SCORE system was between 0 and 4% (median-1, 25–
–75 Q: 0–2). A relationship between SCORE risk and IMT (ANOVA p < 0.001), FMD
(ANOVA p < 0.001), NMD (ANOVA p < 0.001), FMD × BAd index (ANOVA p = 0.017),
but not FMD/NMD index (ANOVA p = 0.27), was found.
Conclusions: The association of a simple stratifying scale (SCORE system) with indices of
early vascular remodeling in a low risk population supports its clinical significance. (Cardiol J
2009; 16, 5: 407–412)
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Introduction
Cardiovascular diseases are the leading cause
of death in civilised countries, including Poland [1].
The SCORE system is a simple, currently recom-
mended method of cardiovascular risk assessment
[2, 3]. SCORE is the result of several European
long-term prospective cohort studies recruiting
altogether more than 200,000 individuals [2].
SCORE allows the evaluation of a ten-year risk
of cardiovascular diseases death based on modifia-
ble and unmodifiable risk factors, including: age, sex,
systolic blood pressure (SBP) and serum concentra-
tions of total cholesterol (TCh). While the limited
number of estimated risk factors is its major advan-
tage, on the other hand opponents point to the lack
of several important risk factors, such as family his-
tory, low density lipoprotein cholesterol (LDL-Ch)
level or obesity [4].
The SCORE-based estimated ten-year risk
≥ 5% indicate a high risk population. However, the
most difficult challenge is to identify the patients
at risk for cardiovascular events in a young low-risk
population. The evaluation might be based either
on the SCORE risk extrapolation for the age of 60
and relative risk or noninvasive methods assessing
early structural and functional changes within ar-
terial vessels. A large body of evidence supports the
role of brachial artery flow mediated dilatation
(FMD) and carotid artery intima-media thickness
(IMT) in this setting. Unfortunately, previous stud-
ies have not provided sufficient conclusions on its
role in a population of young healthy individuals.
The aim of this study is to determine relation-
ships between the traditional cardiovascular risk
factors included in the SCORE system and cardio-
vascular risk estimated with the SCORE system,
IMT and FMD in a low risk population.
Methods
One hundred and nineteen patients (60 women,
59 men) aged between 25 and 50, with no known
cardiovascular disease and a SCORE system-esti-
mated risk < 5%, were included in our study.
The average age between the subpopulations
of men and women were comparable (mean + SD):
38.9 ± 5.5 vs. 38.8 ± 6.0 age (p = 0.96).
The exclusion criteria included any somatic (i.e.
hypothyroidism, Cushing disease, diabetes, impaired
glucose tolerance, systemic hypertension, metabolic
syndrome) or mental diseases, pharmacotherapy (in-
cluding contraception), changes in body weight dur-
ing the three months preceding the start of the study,
ovariectomy, pregnancy, menopause, significant hyper-
lipidemia (TCh ≥ 320 mg/dL, LDL-Ch ≥ 240 mg/dL),
and severe arterial hypertension (≥ 180/110 mm Hg).
The study was approved by the local Ethics
Committee, and all patients gave written informed
consent prior to enrollment.
The clinical characteristics of the patients includ-
ed: medical history, physical examination (arterial pres-
sure, body mass index, and waist/hip ratio), laboratory
tests (mainly lipidograms, fasting glucose), accesso-
ry investigations (electrocardiogram, echocardiogra-
phy), and detailed characteristics of therapy used.
The subjects were instructed to fast overnight and
avoid smoking for 24 hours prior to the examination.
Based on the SCORE system tables by the
Third Joint Task Force of European and Other So-
cieties on Cardiovascular Disease Prevention in
Clinical Practice [2], ten-year risk of cardiovascular
death (for current age and extrapolated for age of 60)
was evaluated for each individual. Lipid parameters
(serum cholesterol, HDL-cholesterol, LDL-choles-
terol, triglycerides) and fasting glucose were ob-
tained immediately by the routine laboratory.
The following vascular ultrasonography tech-
niques [5, 6] were used to assess the functional and
structural remodeling of the vascular system: FMD,
IMT and nitroglycerin mediated dilatation (NMD).
Flow-mediated dilatation
The measurements of brachial artery FMD
were done in a quiet, temperature-controlled room,
between 9 and 11 am. Patients were examined af-
ter at least a ten minute rest; ultrasound examina-
tion was performed in a supine position.
Expert investigators took measurements in
a B-mode presentation using a high frequency
ultrasound system (Philips HDI 4000) equipped
with a vascular software for two-dimensional (2D)
imaging, color and spectral Doppler, an internal elec-
trocardiogram monitor and a high frequency vascu-
lar transducer (multiple-frequency: 7–10 MHz).
The brachial artery of the dominant forearm was
visualized above the antecubital fossa in a longitudi-
nal plane, with a sphygmomanometric cuff on the proxi-
mal portion of the arm. The brachial artery diameter
(BAd) was described as a minimal distance between
’m‘ lines, from the anterior to posterior wall of the
artery. Images were acquired with electrocardiogra-
phy gating; with measurements made in end diasto-
le, which corresponds to the onset of the R wave.
The study was performed in three stages:
— stage 1: baseline BAd and flow measurements
were made, and the average was calculated for
each subject;
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— stage 2: sphygmomanometer cuff was inflated
to 200 mm Hg to occlude arterial inflow for
three minutes;
— stage 3: brachial artery diameter and blood flow
were measured and the mean calculated of
the values obtained 50–60 seconds after cuff
deflation.
Considering these two measurements (base-
line and after-cuff deflation), FMD was calculated
(percentage increase of artery diameter compared
to baseline results).
After a ten minute rest, a sublingual tablet of ni-
troglycerin (0.5 mg) was administered to determine the
maximum obtainable exogenous vasodilatory response.
Brachial artery diameter and blood flow were meas-
ured following NTG, and NMD was determined (NTG-
-induced percentage increase of the artery diameter).
To eliminate the influence of BAd morphology
on FMD values, the FMD × BAd and FMD/NMD
indices were assessed [6].
Intima media thickness
All measurements were performed in the com-
mon carotid arteries 1 to 2 cm proximally to the
carotid bulb. The common carotids were studied in
longitudinal planes with anterior and lateral ap-
proaches. IMT was measured on the posterior wall
of the artery. An average of ten measurements was
used to calculate IMT.
Statistical analysis
All analysis was performed using MedCalc 9.0.
Statistical significance was set at p < 0.05. Conti-
nuous variables were described as mean, standard
deviation, minimum and maximum. SCORE system
was described as median, 25–75%, minimum and
maximum. T-test was used to compare normally
distributed continuous variables. In the case of ab-
normal distribution, the U Mann-Whitney test was
used. Comparisons between subgroups of IMT,
FMD, NMD, FMD × BAd, FMD/NMD classified on
the basis of SCORE system were performed with
one way analysis of variation (ANOVA). Spearman’s
rank correlation test was applied to assess relations
between variables. Stepwise multiple regression
was used to analyze the relationship between a de-
pendent variable: IMT, FMD, NMD, FMD × BAd,
FMD/NMD and independent variables.
Results
Clinical characteristics of the study group are
presented in Table 1. None of the participants re-
vealed serum fasting glucose above 126 mg/dL or
triglycerides above 400 mg/dL.
All the vascular parameters are shown
in Table 2.
The SCORE system parameters and IMT/
/FMD — multivariate regression analysis
We evaluated the association of the SCORE
system parameters (age, sex, smoking, SBP, TCh
concentration) and vascular parameters (IMT,
FMD). IMT values were significantly correlated
with the following: age, SBP, TCh and FMD
(R-adjusted 0.45; p < 0.001). FMD values were signi-
ficantly associated with sex and IMT (R-adjusted
0.24; p < 0.001). NMD values were significantly
correlated with sex and IMT (R-adjusted 0.29;
p < 0.001). Moreover, after inclusion of BAd, the
only factor significantly correlating with FMD and
NMD was BAd (R-adjusted 0.31; p < 0.001; R-ad-
justed 0.44; p < 0.001). The FMD × BAd index and
FMD/NMD ratio were significantly influenced by IMT
(R-adjusted 0.04; p = 0.015; R-adjusted 0.04; p = 0.02).
All the results are presented in Table 3.
The SCORE system
The SCORE-estimated risk for the study pop-
ulation was relatively low: 0 to 4% (median-1, 25–
Table 1. Clinical characteristics.
 Mean SD Minimum Maximum
Age 38.8 5.7 27 50
Systolic blood pressure [mm Hg] 119.8 15.5 90 160
Total cholesterol [mg/dl] 209.6 40.6 139 326
HDL cholesterol [mg/dL] 56.0 12.9 27 95
LDL cholesterol [mg/dL] 124.6 32.6 69 218
Triglicerides [mg/dL] 141.0 91.7 29 397
Glucose [mg/dL] 90.8 9.9 67 121
HDL — high density lipoprotein; LDL — low density lipoprotein
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–75 Q: 0–2). The risk was higher for men than for
women (1% vs. 0%, p < 0.0001). Furthermore, car-
diovascular risk extrapolated for the age of 60 was
as follows: median 4, 25–75 Q: 2–7 (Fig. 1).
Further analysis revealed a significant association
between a ten year risk of cardiovascular death based
on the SCORE system and IMT (ANOVA p < 0.001;
Fig. 2), FMD (ANOVA p < 0.001; Fig. 3), NMD
(ANOVA p < 0.001) and FMD × BAd index (ANOVA
p = 0.017; Fig. 4), which therefore matches to the
SCORE system in terms of low risk range. However,
no relationship has been observed between FMD/
/NMD ratio and SCORE-risk (ANOVA p = 0.272).
There was a significant relationship between ex-
trapolated SCORE-risk and IMT (r = 0.55; p < 0.0001),
FMD (r = –0.46; p < 0.0001), NMD (r = –0.49;
p < 0.0001), FMD × BAd index (r = 0.208; p = 0.024).
But no association was found in terms of FMD/NMD
ratio (r = –0.13; p = 0.16). The difference between
the correlation for FMD and FMD × BAd index was
statistically significant (p = 0.0293).
Table 2. Intima media thickness, brachial artery diameter (BAd), flow mediated dilatation (FMD), nitro-
glycerin mediated dilatation (NMD), FMD × BAd index, FMD/NMD index in the group examined.
Mean SD Minimum Maximum
Intima media thickness [mm] 0.52 0.08 0.37 0.78
Brachial artery diameter [mm] 3.51 0.69 2.4 5.07
Flow mediated dilatation [%] 17.5 7.8 0.73 41.8
Nitroglycerin mediated dilatation (%) 27.0 9.0 8.4 51.0
FMD × BAd 58.2 22.4 3.0 116.0
FMD/NMD 0.64 0.19 0.04 1.06
Table 3. Multiple regressions of dependents: intima media thickness (IMT), flow mediated dilatation
(FMD), nitroglycerin mediated dilatation (NMD), FMD × BAd index, FMD/NMD index.
Independent variables Coefficient Std. error p
Multiple regression of dependent IMT (Constant 0.1037; R-adjusted 0.45; p < 0.001)
Age 0.0044 0.00097 < 0.0001
SBP 0.0018 0.00039 < 0.0001
TCh 0.0003 0.00014 0.03
FMD –0.0021 0.00075 0.006
Multiple regression of dependent FMD (Constant 39.89; R-adjusted 0.31; p < 0.001)
BAd –6.4 0.86 < 0.0001
Multiple regression of dependent NMD (Constant 57.56; R-adjusted 0.44; p < 0.001)
BAd –8.71 0.91 < 0.0001
Multiple regression of dependent FMD × BAd (Constant 89.62; R-adjusted 0.04; p = 0.02)
IMT –60.26 1.63 0.0059
Multiple regression of dependent FMD/NMD (Constant 0.92; R-adjusted 0.04; p = 0.015)
IMT –0.53 0.22 0.015
BAd — brachial artery diameter; SBP — systolic blood pressure; TCh — total cholesterol
Figure 1. Actual, and extrapolated to the age of 60,
cardiovascular risk estimated by use of SCORE system
in the males and females examined.
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Discussion
Our study evaluated a population of young,
apparently healthy individuals of low ten-year risk
of cardiovascular death.
Multivariate regression analysis demonstrat-
ed close associations between IMT and classical
risk factors: age, SBP, TCh and FMD values, which
is in line with previous observations [7–10]. The
Kuopio Ischaemic Heart Disease Risk Factor Study
of 1,165 men demonstrated that SBP constitutes an
independent factor affecting intima-media complex
thickening [7]. Sun et al. [8] provided similar ob-
servations of a population of 1,781 apparently cli-
nically healthy individuals. Moreover, IMT has been
showed to correlate with TCh, HDL-Ch, LDL-Ch
and triglicerides serum concentrations [9, 10].
Our observation showed a significant inverse
correlation between IMT and FMD that was con-
sistent with the literature data [11–13]. IMT cor-
related with FMD in patients without macroscopic
anatomical atherosclerotic lesions. Atherosclero-
tic plaques or substantial IM complex thickening di-
minishes vessel relaxing properties, probably in
a non-linear relation. But vascular parameters re-
flect different stages of atherogenesis: IMT corre-
sponds with large arteries’ remodeling, which starts
early but is predominantly found in elderly patients,
whereas FMD reflects endothelial function.
Reliable interpretation of FMD-dependent re-
gression analysis is more complex. A regression
multifactorial model showed that BAd might affect
up to 31% of FMD values. This was in line with our
previously published data [14]. Making the meas-
ure of FMD independent from BAd by introducing
the FMD × BAd index, the independent factor in-
fluencing the value of the index was IMT. However,
IMT affected only 4% of obtained values.
Similarly to FMD, NMD values were mainly
dependent on BAd. Nonetheless, FMD/NMD ratio,
which is an indirect index of vasorelaxing vascular
properties independent of artery stiffness, revealed
an association only with IMT. Our observations
concerning FMD × BAd and FMD/NMD indices re-
quire further examination.
The estimated ten-year risk of cardiovascular
death in our population was relatively low: 0 to 1%
for up to 74% of participants. Nevertheless, even
in the population of such low cardiovascular risk,
a statistically significant association between the
SCORE system and vascular parameters was found.
Higher-risk individuals revealed thicker intima-
-media complex and decreased FMD. Therefore,
the low risk population is heterogenous and even
Figure 2. Intima media thickness (IMT) and the SCORE
risk.
Figure 4. Flow mediated dilatation (FMD) × brachial
artery diameter (BAd) index and the SCORE risk.
Figure 3. Flow mediated dilatation (FMD) and the
SCORE risk.
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a difference by 1% in the SCORE risk (insignificant
differences in the SCORE system score) was associ-
ated with substantial differences in vascular parame-
ters.
Further analysis also showed a significant as-
sociation of FMD × BAd index with the SCORE
risk. However, as the SCORE system includes male
sex (which is usually accompanied by a larger bra-
chial artery diameter), the described association
was not as strict as for FMD values.
To the best of our knowledge, our study is the
first evaluation of the association between the
SCORE system and vascular parameters. A similar
observation has been confirmed for the Framing-
ham scale. Witte et al. [15] revealed a close corre-
lation between cardiovascular risk factors and FMD
values in individuals with low risk according to the
Framingham scale. The authors concluded that an
increased risk of 1% is accompanied by decreased
FMD values of 1.42%, but only in a population of low
risk patients according to the Framingham scale.
This was not related to higher risk patients [15].
Our results confirm beyond doubt a reliable as-
sociation of a simple stratifying scale (the SCORE
system) with indices of early vascular remodeling in
a low risk population. Every increase by 1% in the
SCORE risk corresponds with more advanced vascu-
lar abnormalities. It supports the clinical significance
of the SCORE system. Moreover, it suggests that
analysis of vascular indices may constitute an alter-
native method of risk stratification. Both the SCORE
system and vascular parameters analysis, including
FMD, IMT may be useful in identifying young, appar-
ently healthy individuals requiring systematic check-
ups and intensive lifestyle modification.
Conclusions
In a population of low cardiovascular risk, inti-
ma-media thickness is determined by classical risk
factors included in the SCORE system. FMD va-
lues are closely dependent on the brachial artery
diameter that in FMD assessment the artery diam-
eter should be taken into account. Both FMD ×
× BAd index and FMD/NMD ratio have been
showed to be related to IMT.
Young adults without clinically apparent cardi-
ovascular diseases are characterized by low and
sex-dependent risk according to SCORE. There are
observed relationships between the SCORE risk
and IMT and FMD values.
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